INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

6,734 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
42
AL
Aviram LiorDirector
CAMTCAMTEK LTD
Open-market sale
SELL$294K
1,681 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
Page 49 of 169
← PrevNext →
+1d
SEC Form 4

Evidence

42
PS
Pariaros SymeonChief Administrative Officer
EDRYEuroDry Ltd.
Open-market sale
SELL$76K
1,900 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

42
AL
Aviram LiorDirector
CAMTCAMTEK LTD
Open-market sale
SELL$288K
1,666 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

39
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Open-market sale
SELL$5.78M
32.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

39
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Open-market sale
SELL$5.00M
28.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

39
Carol D. MillerRSelf
TGTTARGET CORP
Sale
SELL$15K – $50KMar 10, 2025Aug 13, 2026
traded Mar 10, 2025
+521dHouse PTR

Evidence

39
Carol D. MillerRSelf
PFEPFIZER INC
Sale
SELL$15K – $50KMar 10, 2025Aug 13, 2026
traded Mar 10, 2025
+521dHouse PTR

Evidence

39
Shri ThanedarDSelf
MSTRStrategy Inc
Sale
SELL$15K – $50KOct 21, 2025Aug 13, 2026
traded Oct 21, 2025
+296dHouse PTR

Evidence

39
Carol D. MillerRSelf
DGXQUEST DIAGNOSTICS INC
Sale
SELL$15K – $50KMar 10, 2025Aug 13, 2026
traded Mar 10, 2025
+521dHouse PTR

Evidence

39
Carol D. MillerRSelf
USBUS BANCORP DE
Sale
SELL$15K – $50KMar 10, 2025Aug 13, 2026
traded Mar 10, 2025
+521dHouse PTR

Evidence

38
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$154K
6,970 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

38
TE
Taylor Timothy EvanDirector, VP, Finance & Operations
GSATGlobalstar, Inc.
Open-market sale
SELL$6.24M
75.0K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

38
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
1,680 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

38
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$146K
6,763 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

36
NA
Nanduru AnilSenior Vice President
GGenpact LTD
Open-market sale
SELL$586K
17.2K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
MH
Morrone Louis H.EXECUTIVE VICE PRESIDENT
ABTABBOTT LABORATORIES
Open-market sale
SELL$643K
5,850 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
WD
Woolson DanielVP, GM-Infusion Capital
ICUIICU MEDICAL INC/DE
Open-market sale
SELL$982K
5,417 sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC Form 4

Evidence

36
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$9.28M
104.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
WK
Wanninger KurtEVP & Chief Operations Officer
MBCMasterBrand, Inc.
Open-market sale
SELL$461K
50.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$3.14M
19.0K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

36
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.36M
15.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$2.20M
13.2K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

35
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
455 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

35
EM
Eisenberg MosheChief Financial Officer
CAMTCAMTEK LTD
Open-market sale
SELL$111K
645 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

35
Derek TranDSelf
LTCLTC PROPERTIES INC
Sale
SELL$1,001 – $15KJul 28, 2025Aug 13, 2026
traded Jul 28, 2025
+381dHouse PTR

Evidence

35
PJ
Polak Aldo J.Director
EVTCEVERTEC, Inc.
Open-market sale
SELL$30K
1,000 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

35
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
315 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

34
TE
Taylor Timothy EvanDirector, VP, Finance & Operations
GSATGlobalstar, Inc.
Open-market sale
SELL$6.21M
75.0K sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC Form 4

Evidence

34
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$75K
3,402 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

34
SH
Shah HusnalChief Product Officer
FNKOFunko, Inc.
Open-market sale
SELL$52K
8,800 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

32
RENAISSANCE TECHNOLOGIES LLC13F filer
UNHUNITEDHEALTH GROUP INC
TRIM
SELL$328.94M
791.4K sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

32
RENAISSANCE TECHNOLOGIES LLC13F filer
LINLINDE PLC
TRIM
SELL$324.19M
624.7K sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

32
RENAISSANCE TECHNOLOGIES LLC13F filer
RMROBINHOOD MKTS INC
TRIM
SELL$291.59M
2.91M sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

32
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.63M
9,934 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

32
NA
Nanduru AnilSenior Vice President
GGenpact LTD
Open-market sale
SELL$402K
11.9K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.52M
28.7K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

32
TA
Tezel AhmetChief Innovation Officer
LIVNLivaNova PLC
Open-market sale
SELL$208K
2,675 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5.62M
62.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$4,410
200 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$26K
1,163 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence